Antibiotic medicines: Bill of materials
About these figures
Which unit, study and year the composition figures describe, and how they vary
No source opened gives the make-up of a course in grams or lists its other ingredients. The active ingredient is a penicillin or another antibiotic, made upstream through intermediates such as 6-APA and 7-ACA [2][16]. Tablets [19], capsules [24] and powder oral suspensions [15] are sold. The primary pack and the excipients are not yet product nodes. Stages are named only: no strains, methods, conditions or recipes are given.
as of 2026-11-14
Direct materials
The commodities and chemicals in one unit as bought, with amount, mass share, cost share and recycled content
| Material | Role | Amount in one unit | Share of the unit's mass |
|---|---|---|---|
| API Small-molecule APIs | Functional | Not given | – |
| The active ingredient is an antibiotic compound; WHO's guidance covers the steps from making it to formulating finished products, including primary packaging [1]. No source opened gives the mass per course. | |||
as of 2026-11-14
How it is put together
The main steps from parts and materials to the finished unit
| Step | What happens | Source |
|---|---|---|
| Intermediate | Building blocks such as 6-APA and 7-ACA are made; the steps are not described here | [2][16] |
| Active ingredient | The active pharmaceutical ingredient is made; the steps are not described here | [1] |
| Formulation | The ingredient is formulated into finished products such as tablets, capsules and powder oral suspensions | [1][19][24][15] |
| Primary packaging | The finished product goes into its primary pack before sale | [1] |
as of 2026-11-14
Sources
- New global guidance aims to curb antibiotic pollution from manufacturing World Health Organization, 2024, news release of 3 September 2024
- Foreign control of antibiotic supply: American and European import reliance and systemic vulnerabilities (Report No. 2026/06) Council on Geostrategy with the Coalition for a Prosperous America, 2026, think-tank report by Andrew Rechenberg (economist, Coalition for a Prosperous America, an advocacy group) and Patrick Triglavcanin (Council on Geostrategy); ISBN 978-1-917893-22-0; no publication month, no method section and no footnotes for the figures
- Sandoz opens antibiotic production facility in Austria CHEManager International, 2024, 26 March 2024; company claims reported by a trade publication
- Aurobindo Pharma, KAPL get approval for promotion of manufacturing bulk drugs Medical Dialogues, 2021, 24 January 2021, by Ruchika Sharma, citing PTI and a Ministry of Chemicals and Fertilizers statement
- NPPA Hikes Prices of Key Antibiotics Azithromycin, Amoxicillin Clavulanic Acid Medical Dialogues, 2025, 12 February 2025, by Farhat Nasim; reports the review order dated 4 October 2024
- The environmental impact of antibiotics Irish Pharmacy Union (IPU Review; Ellen Martin, HSE AMRIC team), 2025, May 2025; review article citing Taylor et al. (2024)